NICOLE ENGLERT: Open Payments
NPI 1104993674 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 100 payments from 21 companies in 2025. Trend: 2023 $2,305 · 2024 $3,341 · 2025 $2,364
Food & beverage: $2,304Consulting: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $817 |
| LEO Pharma Inc. | 13 | $207 |
| GENZYME CORPORATION | 8 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $175 |
| GlaxoSmithKline, LLC. | 8 | $160 |
| Novartis Pharmaceuticals Corporation | 7 | $146 |
| BioCryst US Sales Co., LLC | 3 | $84 |
| ABBVIE INC. | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| ADMA BioManufacturing LLC | 6 | $60 |
Products named: AIRSUPRA, DUPIXENT, ADBRY, FASENRA, CUVITRU, NUCALA, ORLADEYO, RINVOQ.
Industry payments across AZ — which companies pay providers there.
